Patheon is a global provider of development and commercial manufacturing services for solid and sterile prescription drugs, offering a wide variety of services and products. SEE AND Read More »

Andrea Como

Andrea Como

Sr. Manager, Site Technical Business

Mr. Como oversees our technology transfer and technical business management teams at our sterile and solid dose facility in Monza, Italy. He joined Patheon in 2005 as a Technology Transfer Specialist. After two years he moved to the business management department, becoming Business Manager in 2008, then was appointed Site Technical Business Manager in 2010. +

ask me a question
Anil Kane, Ph.D., MBA

Anil Kane, Ph.D., MBA

Executive Director, Global Formulation Sciences, PDS

Dr. Kane has more than 25 years of experience in the science and business of taking molecules through the entire drug development process. His extensive knowledge spans early stage development to scale-up and commercial manufacturing, and includes technical transfers between global sites and drug lifecycle management. +

ask me a question
Kaspar van den Dries, Ph.D.

Kaspar van den Dries, Ph.D.

Director, R&D Europe

Based at our Tilburg facility in the Netherlands, Dr. van den Dries leads Patheon’s European research and development team in the development of innovative softgel formulations, processes and technologies to better meet the needs of pharmaceutical companies and patients. He is an expert in the formulation of poorly soluble compounds and self-emulsifying drug delivery systems with experience spanning the entire solid dose form development cycle. +

ask me a question
Bob Zinser, M.S. Chemistry, MBA

Bob Zinser, M.S. Chemistry, MBA

VP, Commercial Technology North America

Mr. Zinser offers Patheon customers the advantage of more than 39 years’ experience in pharmaceutical manufacturing planning, processes and technologies. With a blend of both technical and business expertise, he brings a unique big-picture point of view to all his projects. +

ask me a question
Enrico Corona

Enrico Corona

PDS, Formulation and Production Manager

Since joining Patheon in 2003, Mr. Corona has been vital in the development of new liquid and lyophilized parenteral formulations for preclinical and clinical trials, as well as their commercialization. He conducts lyophilization cycle development and presides over our scale-up to fill-finish sterile suite. +

ask me a question
Geoff Carr, Ph.D.

Geoff Carr, Ph.D.

Director, Analytical Development

Dr. Carr offers Patheon customers 36 years of applying analytical science to the creation of pharmaceutical products. His expertise includes the development and validation of analytical methods, use of spectroscopic techniques to identify impurities, specification development for APIs and drug products design, API characterization, drug degradation chemistry, and management of stability programs. +

ask me a question
Giuseppe Cassisi, MBA

Giuseppe Cassisi, MBA

VP, Global Business Management

With a solid foundation of marketing and sales, and expertise in the licensing of generics and drug delivery systems, Mr. Cassisi applies his deep knowledge of the pharmaceuticals industry to Patheon’s global strategic business development. +

ask me a question
Gordon Marr, Ph.D.

Gordon Marr, Ph.D.

Associate Director, PDS Analytical Development

Dr. Marr is an expert in computer-aided analytical method development, optimization and validation for APIs and drug products. He is also an expert in the development of stability programs and troubleshooting of analytical methods. +

ask me a question
Harry Gill

Harry Gill

Sr. VP Quality and Continuous Improvement

Mr. Gill has amassed a broad range of expertise in his 25 years of global pharmaceutical operations and product development. He has direct experience in plant operations management, QA and QC laboratory management, aseptic manufacturing, large volume parenterals, delivery devices, and the majority of solid dose forms. Mr. Gill has also lead operational excellence transformations in multiple companies. +

ask me a question
Jason Vaughn, Ph.D.

Jason Vaughn, Ph.D.

Director, Formulation and Product Development

Dr. Vaughn has expertise in early and preclinical development of liquid, semi-solid and solid dosage formulations, including hot melt extrusion and enhancement of solubility and bioavailability. +

ask me a question
Mirko Gabriele, MBA

Mirko Gabriele, MBA

Technology Transfer Project Manager

An expert in scale-up and technology transfers, Mr. Gabriele’s 10 years of pharmaceutical industry experience includes API bulk production, quality control, and research and development. His experience includes the evaluation of new projects and client relationship management. +

ask me a question
Roman Hlodan, Ph.D.

Roman Hlodan, Ph.D.

Biopharmaceutical Specialist

Dr. Hlodan is an expert in the development of biopharmaceuticals, including analytical method development and validation, stability program management, and formulation development. +

ask me a question
Stefano Chiaramonti, Ph.D.

Stefano Chiaramonti, Ph.D.

Group Director of Operations, PDS

With 17 years of experience in pharmaceutical development and operations leadership in Europe, and as a certified Qualified Person (QP), Dr. Chiaramonti is an expert in quality and EU regulatory requirements. +

ask me a question
Stephen Closs

Stephen Closs

Director, Global Technical Affairs

Mr. Closs possess more than 23 years of experience in formulation development, tech transfer, scale-up and commercialization of solid dosage pharmaceuticals. He is an expert in process analytical technologies (PAT), Quality by Design (QbD), and process optimization and development. +

ask me a question
Tony Pidgeon

Tony Pidgeon

Senior Manager, Global Science and Technology

Mr. Pidgeon has nearly three decades of experience in the formulation and process development of sterile and solid products, both small molecule and biopharmaceuticals. He is an expert in the exploitation of the advantages of disposable (single-use) manufacturing technologies. +

ask me a question
William E. Weiser, Ph.D.

William E. Weiser, Ph.D.

Global Head, PDS Analytical Sciences

Dr. Weiser is an expert in analytical method development and validation for APIs and drug products. His expertise includes stability program development, analytical method troubleshooting, preparation of the CMC Section of IND/NDA/CTD submissions, and U.S. agency for European API manufacturers. +

ask me a question
Ann Newman, Ph.D.

Ann Newman, Ph.D.

Principal Consultant, Seventh Street Development Group

Dr. Newman’s expertise is in solid-state chemistry: physical forms, polymorphism, salts, cocrystals, and amorphous solid dispersions, including screening, characterization, form selection, and process induced transformations. In her more than 25 years in the industry, she has played a key role in the development of more than eight successfully launched commercial products. +

ask me a question
Robert A. Lipper, Ph.D.

Robert A. Lipper, Ph.D.

President, BACK COVE PHARMA, LLC

Having ushered multiple products to market though the entire development process, Dr. Lipper is an expert in the efficient transition from discovery to proof of concept and beyond. This includes evaluation of the "developability" of new chemical entities, diagnosing and recommending solutions to bioavailability challenges, development strategies, and CMC regulatory strategies. +

ask me a question
Joseph A. Fix, MBA, Ph.D.

Joseph A. Fix, MBA, Ph.D.

President, Pharma-Fix Consulting LLC

With 30 years of experience converting discoveries into businesses, Dr. Fix holds 24 patents, including 4 NECs, 13 LCMs, 4 OTCs, and 3 generics. His expertise is the business of the business: Strategic planning and implementation, business and technology integration, in/out licensing due diligence, and all aspects of product development. Dr. Fix is an expert in laying the foundation for lasting pharmaceutical companies. +

ask me a question
John S. Kent, Ph.D.

John S. Kent, Ph.D.

Principal, Pharmaceutical Development Consulting

With over 35 years of experience, Dr. Kent offers expertise in overcoming development challenges for orals, topicals and ophthalmics, plus specialized expertise in sterile products. He has proven experience resolving organizational, productivity and global regulatory issues. His contributions have resulted in more than 20 commercial products and multiple CMC IND and NDA filings. +

ask me a question
K. George Mooney, Ph.D.

K. George Mooney, Ph.D.

President, Kom Pharma Consulting, LLC

Dr. Mooney has 35 years’ experience in pharmaceutical sciences and exploratory drug development. He combines in-depth pharmaceutical knowledge with experience in multiple scientific applications to provide clients an optimal path to the achievement of drug candidate goals. Dr. Mooney has contributed to more than 30 NDA product filings and over 100 IND filings and has led large multidisciplinary groups in the Pharmaceutical Industry. +

ask me a question
Larry Gatlin, Ph.D.

Larry Gatlin, Ph.D.

Leader - Manager, Scientist, Mentor -- Biotechnology & Pharmaceutical

Dr. Gatlin is an industry veteran with more than 36 years of scientific and leadership experience. He is an expert in the formulation and process development of sterile and biopharmaceutical products. He has expertise in small and large molecules, as well as lyophilization. He is also a recognized expert in process optimization and personnel development. +

ask me a question
Lynn Van Campen, Ph.D.

Lynn Van Campen, Ph.D.

Consultant, Zeeh Pharmaceutical Experiment Station University of Wisconsin — Madison

With more than 30 years of drug development experience, Dr. Van Campen is an expert in the establishment of best practices in large, mid-size and start-up organizations. She is a proven scientist, manager and executive who has played key roles in the development and launch of 18 products representing 8 dosage forms, and 3 devices. She has special expertise with dry powder and metered dose inhalation product development. +

ask me a question
Mark A. Staples, Ph.D.

Mark A. Staples, Ph.D.

Principal Cusp PharmaTech Consulting LLCle

Having worked 32 years with all early to mid-stage companies, Dr. Staples is an expert at the early development of small organic molecules, peptides, proteins, biologics, and combination products. He offers specialized expertise in the management of outsourced lab and manufacturing resources, as well as the collection and compilation of data for the Chemistry, Manufacturing and Controls (CMC) section of Regulatory submissions. +

ask me a question
Rodney Pearlman, PhD.

Rodney Pearlman, PhD.

RPM Pharma

An expert in the development of scientific and business strategies for start-ups, Dr. Pearlman brings a unique balance of experience from the lab as well as the corner office. He has lead numerous emerging companies through the development of formulations, processes and delivery systems, while at the same time hiring management teams, raising capital and establishing operations plans. +

ask me a question
Leah Appel, Ph.D.

Leah Appel, Ph.D.

Managing Partner, Green Ridge Consulting

Dr. Appel has over 20 years’ experience in the pharmaceutical industry developing drug delivery technologies and products. She is an expert in oral solid dosage forms including controlled release and delivery of poorly soluble compounds. She is an inventor on 35 drug delivery patents and patent applications. +

ask me a question
Bret Berner, Ph.D.

Bret Berner, Ph.D.

Pharmaceutical Consultant

Dr. Berner holds more than 40 patents in various areas of drug delivery, but is an internationally recognized expert in controlled release, oral and transdermal technologies. In accomplishing these breakthroughs, he has led formulation, clinical and regulatory development and patent activities, and has expertise in analytical chemistry. +

ask me a question

Knowledge Library


Please fill the below form to access requested content

First Name

Last Name

Company

Title

Email

Phone

Address Line 1

Address Line 2

City

State / Province

Zip/ Postal Code

Country

Submit

Ask a Question


*
*
*
Submit your question

Event Enrollment


First Name

Last Name

Company

Title

Email

*

Phone

Address Line 1

Address Line 2

City

State / Province

Zip/ Postal Code

Country

Submit

登録フォーム


*

*

姓 (カタカナ)

名(カタカナ)

会社名

*

郵便番号

役職

住所1

Email

* *

住所2

電話

*

送信

Apply Now


[Title,jobs]

[Location,jobs] - [Region,jobs]

First Name

Last Name

Email Address

Country

Address Line 1

Address Line 2

City

State / Province

Zip/ Postal Code

Daytime Phone

Evening Phone

Resume

Submit